- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Pricing
- SKY Learn
- Mutual Funds
- Margin Trading
- Financial Planning
- Personal Finance
- Share Trading
- IPO
- Derivatives
- Currencies
- Intraday Trading
- Trading Strategies
- Demat Account
- Commodity
- ETF
Dr Agarwals Healthcare IPO
₹13,370/35 shares
Minimum Investment
IPO Details
29 Jan 25
31 Jan 25
₹13,370
35
₹382 to ₹402
NSE, BSE
₹3 Cr
05 Feb 25
Dr Agarwals Healthcare IPO Timeline
Bidding Start
29 Jan 25
Bidding Ends
31 Jan 25
Allotment Finalisation
03 Feb 25
Refund Initiation
04 Feb 25
Demat Transfer
04 Feb 25
Listing
05 Feb 25
Explore IPO Opportunities
Explore our comprehensive IPO pages to stay updated on the latest trends and insights.
About Dr. Agarwal’s Healthcare Limited IPO
Dr. Agarwal’s Healthcare Limited offers a comprehensive range of eye care services, including cataract, refractive, and other surgeries, along with consultations, diagnoses, and non-surgical treatments. The company also provides opticals, contact lenses, accessories, and eye care-related pharmaceutical products. In the Financial Year 2024, it held approximately 25% market share in India’s eye care service chain market (Source: CRISIL MI&A Report). With a long-standing operational history, it addresses patients’ needs through a network of 180 facilities as of March 31, 2024, the highest among peers in India.
IPO Strengths
- India’s leading provider of trusted eye care services.
- Offering comprehensive, end-to-end eye care solutions.
- Scalable, asset-light model with a hub-and-spoke approach.
- Strong clinical board and a legacy of surgical innovations drive clinical excellence.
- Led by doctor-promoters and a skilled medical team, supported by an experienced management team.
- Demonstrated success in achieving organic growth, integrating acquisitions, and enhancing operational profitability.
Dr. Agarwal’s Healthcare IPO Key Financials (in ₹ million)
| Particulars | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 27,528.16 | 18,251.74 | 10,261.34 |
| Revenue | 13,321.52 | 10,179.80 | 6960.78 |
| Profit After Tax | 950.51 | 1032.30 | 431.64 |
| Reserves and Surplus | 13,300.48 | 6216.31 | 2055.17 |
| Total Borrowings | 3877.87 | 3561.77 | 2901.80 |
Dr. Agarwal’s Healthcare Limited Upcoming IPO Details
| Category | Details |
| Issue Type | Book Built Issue IPO |
| Total Issue Size | Fresh Issue: 74,62,686 shares (aggregating up to ₹ 300.00 Cr)
Offer for Sale: 6,78,42,284 shares (aggregating up to ₹2,727.26 Cr) |
| Price Range | ₹382 to ₹405 per share |
| Lot Size | 35 Shares |
| Face Value | ₹1 per share |
| Listing Exchange | NSE, BSE |
| Pre-IPO Shareholding | 30,84,17,160 shares |
| Post-IPO Shareholding | 31,58,79,846 shares |
Dr. Agarwal’s Healthcare IPO Important Dates
| IPO Activity | Date |
| IPO Open Date | 29 January 2025 |
| IPO Close Date | 31 January 2025 |
| Basis of Allotment | 3 February 2025 |
| Refunds Initiation | 4 February 2025 |
| Credit of Shares to Demat | 4 February 2025 |
| Listing Date | 5 February 2025 |
Dr. Agarwal’s Healthcare IPO Lots
| Application | Lots | Shares | Amount |
| Retail (Min) | 1 | 35 | ₹14,070 |
| Retail (Max) | 14 | 490 | ₹1,96,980 |
| S-HNI (Min) | 15 | 525 | ₹2,11,050 |
| S-HNI (Max) | 71 | 2485 | ₹9,98,970 |
| B-HNI (Min) | 72 | 2520 | ₹10,13,040 |
Dr. Agarwal’s Healthcare IPO Lead Managers
| Lead Managers |
| Kotak Mahindra Capital Company Limited |
| Morgan Stanley India Company Private Limited |
| Jefferies India Private Limited |
| Motilal Oswal Investment Advisors Limited |
Dr. Agarwal’s Healthcare Limited IPO Valuation Overview
| KPI | Value |
| Earnings Per Share (EPS) | 3.14 |
| Price/Earnings (P/E) Ratio | TBD |
| Return on Net Worth (RoNW) | 6.21% |
| Net Asset Value (NAV) | 50.53 |
| Return on Equity | 9.33% |
| Return on Capital Employed (ROCE) | 14.61% |
| EBITDA Margin | 29.54% |
| PAT Margin | 7.14% |
| Debt to Equity Ratio | 0.27 |
Dr. Agarwal’s Healthcare IPO Peer Group Comparison
| Name of the Company | Revenue (₹ in Millions) | Face Value (₹ per Share) | P/E Ratio | Basic EPS (₹) | RoNW (%) | NAV (₹) |
| Dr. Agarwal’s Health Care Limited | 13,321.52 | 1 | – | 3.14 | 6.21% | 50.53 |
| Listed Peers | ||||||
| Apollo Hospitals Enterprise Limited | 190,592.00 | 5 | 113.47 | 62.50 | 12.97% | 481.93 |
| Max Healthcare Institute Limited | 68,490.00 | 10 | 98.56 | 10.89 | 12.58% | 86.54 |
| Fortis Healthcare Limited | 68,929.20 | 10 | 76.33 | 7.93 | 7.82% | 101.48 |
| Global Health Limited | 32,751.11 | 2 | 62.32 | 17.80 | 16.46% | 108.17 |
| Narayana Hrudayalaya Limited | 50,182.49 | 10 | 32.04 | 38.86 | 27.37% | 141.98 |
| Krishna Institute Of Medical Sciences Limited | 24,981.44 | 10 | 14.13 | 38.75 | 16.96% | 228.47 |
| Aster DM Healthcare Limited | 36,989.00 | 10 | 162.10 | 2.60 | 3.63% | 71.62 |
| Rainbow Children’s Medicare Limited | 12,969.00 | 10 | 64.46 | 21.38 | 17.24% | 124.03 |
Objectives of the Proceeds
- Repayment/prepayment, in part or full, of certain of borrowings ₹1,950.00 million
- To meet general corporate expenses
How to apply IPO with HDFC SKY?
Follow these simple steps to apply for an IPO through HDFC SKY. Secure your investments and explore new opportunities with ease by accessing the IPOs available on the platform.
1Login to your HDFC SKY Account
2Select Issue
3Enter Number of Lots and your Price.
4Enter UPI ID
5Complete Transaction on Your UPI App
